Literature DB >> 29281825

Somatic Mutations Activating the mTOR Pathway in Dorsal Telencephalic Progenitors Cause a Continuum of Cortical Dysplasias.

Alissa M D'Gama1, Mollie B Woodworth1, Amer A Hossain1, Sara Bizzotto1, Nicole E Hatem1, Christopher M LaCoursiere2, Imad Najm3, Zhong Ying3, Edward Yang4, A James Barkovich5, David J Kwiatkowski6, Harry V Vinters7, Joseph R Madsen8, Gary W Mathern9, Ingmar Blümcke10, Annapurna Poduri11, Christopher A Walsh12.   

Abstract

Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) are epileptogenic neurodevelopmental malformations caused by mutations in mTOR pathway genes. Deep sequencing of these genes in FCD/HME brain tissue identified an etiology in 27 of 66 cases (41%). Radiographically indistinguishable lesions are caused by somatic activating mutations in AKT3, MTOR, and PIK3CA and germline loss-of-function mutations in DEPDC5, NPRL2, and TSC1/2, including TSC2 mutations in isolated HME demonstrating a "two-hit" model. Mutations in the same gene cause a disease continuum from FCD to HME to bilateral brain overgrowth, reflecting the progenitor cell and developmental time when the mutation occurred. Single-cell sequencing demonstrated mTOR activation in neurons in all lesions. Conditional Pik3ca activation in the mouse cortex showed that mTOR activation in excitatory neurons and glia, but not interneurons, is sufficient for abnormal cortical overgrowth. These data suggest that mTOR activation in dorsal telencephalic progenitors, in some cases specifically the excitatory neuron lineage, causes cortical dysplasia.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  brain malformations; cortical development; epilepsy; excitatory neurons; focal cortical dysplasia; hemimegalancephaly; mTOR pathway; next-generation sequencing; single-cell sequencing; somatic mutations

Mesh:

Substances:

Year:  2017        PMID: 29281825      PMCID: PMC5752134          DOI: 10.1016/j.celrep.2017.11.106

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  52 in total

1.  Biallelic TSC gene inactivation in tuberous sclerosis complex.

Authors:  Peter B Crino; Eleonora Aronica; Gordon Baltuch; Katherine L Nathanson
Journal:  Neurology       Date:  2010-05-25       Impact factor: 9.910

Review 2.  Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis.

Authors:  A C Jones; M M Shyamsundar; M W Thomas; J Maynard; S Idziaszczyk; S Tomkins; J R Sampson; J P Cheadle
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

3.  Somatic activation of AKT3 causes hemispheric developmental brain malformations.

Authors:  Annapurna Poduri; Gilad D Evrony; Xuyu Cai; Princess Christina Elhosary; Rameen Beroukhim; Maria K Lehtinen; L Benjamin Hills; Erin L Heinzen; Anthony Hill; R Sean Hill; Brenda J Barry; Blaise F D Bourgeois; James J Riviello; A James Barkovich; Peter M Black; Keith L Ligon; Christopher A Walsh
Journal:  Neuron       Date:  2012-04-12       Impact factor: 17.173

Review 4.  The neurology of mTOR.

Authors:  Jonathan O Lipton; Mustafa Sahin
Journal:  Neuron       Date:  2014-10-22       Impact factor: 17.173

5.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

6.  Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome.

Authors:  Kyle C Kurek; Valerie L Luks; Ugur M Ayturk; Ahmad I Alomari; Steven J Fishman; Samantha A Spencer; John B Mulliken; Margot E Bowen; Guilherme L Yamamoto; Harry P W Kozakewich; Matthew L Warman
Journal:  Am J Hum Genet       Date:  2012-05-31       Impact factor: 11.025

7.  Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.

Authors:  Ling-Hui Zeng; Nicholas R Rensing; Bo Zhang; David H Gutmann; Michael J Gambello; Michael Wong
Journal:  Hum Mol Genet       Date:  2010-11-09       Impact factor: 6.150

8.  Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3.

Authors:  Joe C Sim; Thomas Scerri; Miriam Fanjul-Fernández; Jessica R Riseley; Greta Gillies; Kate Pope; Hanna van Roozendaal; Julian I Heng; Simone A Mandelstam; George McGillivray; Duncan MacGregor; Lakshminarayanan Kannan; Wirginia Maixner; A Simon Harvey; David J Amor; Martin B Delatycki; Peter B Crino; Melanie Bahlo; Paul J Lockhart; Richard J Leventer
Journal:  Ann Neurol       Date:  2015-12-12       Impact factor: 10.422

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Childhood-Onset Epileptic Encephalopathy Associated With Isolated Focal Cortical Dysplasia and a Novel TSC1 Germline Mutation.

Authors:  Hannes Hoelz; Eva Coppenrath; Konstanze Hoertnagel; Timo Roser; Moritz Tacke; Lucia Gerstl; Ingo Borggraefe
Journal:  Clin EEG Neurosci       Date:  2017-03-07       Impact factor: 1.843

View more
  84 in total

1.  RHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity.

Authors:  Martina Proietti Onori; Linda M C Koene; Carmen B Schäfer; Mark Nellist; Marcel de Brito van Velze; Zhenyu Gao; Ype Elgersma; Geeske M van Woerden
Journal:  PLoS Biol       Date:  2021-05-26       Impact factor: 8.029

2.  DEPDC5 takes a second hit in familial focal epilepsy.

Authors:  Matthew P Anderson
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

Review 3.  New frontiers in modeling tuberous sclerosis with human stem cell-derived neurons and brain organoids.

Authors:  John D Blair; Helen S Bateup
Journal:  Dev Dyn       Date:  2019-05-23       Impact factor: 3.780

Review 4.  The role of somatic mutational events in the pathogenesis of epilepsy.

Authors:  Philip H Iffland; Peter B Crino
Journal:  Curr Opin Neurol       Date:  2019-04       Impact factor: 5.710

5.  Malformations of Cerebral Cortex Development: Molecules and Mechanisms.

Authors:  Gordana Juric-Sekhar; Robert F Hevner
Journal:  Annu Rev Pathol       Date:  2019-01-24       Impact factor: 23.472

6.  Genome aging: somatic mutation in the brain links age-related decline with disease and nominates pathogenic mechanisms.

Authors:  Michael A Lodato; Christopher A Walsh
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

Review 7.  Somatic variants in epilepsy - advancing gene discovery and disease mechanisms.

Authors:  Erin L Heinzen
Journal:  Curr Opin Genet Dev       Date:  2020-05-15       Impact factor: 5.578

8.  Assessment of genetic variant burden in epilepsy-associated brain lesions.

Authors:  Lisa-Marie Niestroj; Patrick May; Mykyta Artomov; Katja Kobow; Roland Coras; Eduardo Pérez-Palma; Janine Altmüller; Holger Thiele; Peter Nürnberg; Costin Leu; Aarno Palotie; Mark J Daly; Karl Martin Klein; Rudi Beschorner; Yvonne G Weber; Ingmar Blümcke; Dennis Lal
Journal:  Eur J Hum Genet       Date:  2019-07-29       Impact factor: 4.246

9.  Prevention of premature death and seizures in a Depdc5 mouse epilepsy model through inhibition of mTORC1.

Authors:  Lindsay K Klofas; Brittany P Short; Chengwen Zhou; Robert P Carson
Journal:  Hum Mol Genet       Date:  2020-05-28       Impact factor: 6.150

10.  mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.

Authors:  Lena H Nguyen; Travorn Mahadeo; Angélique Bordey
Journal:  J Neurosci       Date:  2019-01-30       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.